Difference between revisions of "Part:BBa K4361311"
(2 intermediate revisions by one other user not shown) | |||
Line 3: | Line 3: | ||
<partinfo>BBa_K4361311 short</partinfo> | <partinfo>BBa_K4361311 short</partinfo> | ||
− | A mutant of the BlcR protein, created through site-directed mutagenesis with primers R3 ([[Part:BBa_K4361218]]) and F3.2 | + | A mutant of the BlcR protein, created through site-directed mutagenesis with primers R3 ([[Part:BBa_K4361218]]) and F3.2 L66A ([[Part:BBa_K4361220]]). For this mutant, the leucine in position 66 has been changed to alanine by mutating the CTC codon to GCG. |
This mutant also contains the following nucleotide mutations outside of the targeted site: | This mutant also contains the following nucleotide mutations outside of the targeted site: | ||
Line 15: | Line 15: | ||
<!-- --> | <!-- --> | ||
− | <span class='h3bb'>Sequence and Features</span> | + | <span class='h3bb'><h3>Sequence and Features</h3></span> |
<partinfo>BBa_K4361311 SequenceAndFeatures</partinfo> | <partinfo>BBa_K4361311 SequenceAndFeatures</partinfo> | ||
+ | <html> | ||
+ | <h3>Usage and Biology</h3> | ||
+ | The set of BlcR mutants (</html>[[Part:BBa_K4361300]] through [[Part:BBa_K4361319]]<html>) were expressed in a PURE system in the presence of GreenLys (fluorescent Cy2-labeled lysine). Samples were then run on an SDS PAGE gel (<b>Figure 1.</b>) to determine whether or not the protein was produced. For this mutant (<u>lane 12</u>), a protein band corresponding to the BlcR monomer is visible. Concluding that the production in an E. coli cell-free system was successful for this mutant. | ||
+ | <figure> | ||
+ | <a href="https://static.igem.wiki/teams/4361/wiki/results/figure-7-pure/figure-7-pure-12.png"><img src="https://static.igem.wiki/teams/4361/wiki/results/figure-7-pure/figure-7-pure-12.png" style="width:600px;margin-left:125px"></a> | ||
+ | <figcaption> <b>Figure 1.</b> SDS PAGE showing the translation products of 20 different plasmids coding for BlcR mutants. PURE reaction solution was supplemented with GreenLys and the synthesized proteins were imaged with Typhoon using a 488-nm laser. C: negative control with no plasmid. WT: positive control with expressed wildtype BlcR. 12: L66A mutant</figcaption> | ||
+ | </figure> | ||
+ | |||
+ | |||
+ | </html> | ||
<!-- Uncomment this to enable Functional Parameter display | <!-- Uncomment this to enable Functional Parameter display |
Latest revision as of 15:54, 12 October 2022
BlcR L66A
A mutant of the BlcR protein, created through site-directed mutagenesis with primers R3 (Part:BBa_K4361218) and F3.2 L66A (Part:BBa_K4361220). For this mutant, the leucine in position 66 has been changed to alanine by mutating the CTC codon to GCG.
This mutant also contains the following nucleotide mutations outside of the targeted site:
- T 826 > A, resulting in possible loss of the stop codon
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 694
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 78
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 589
Usage and Biology
The set of BlcR mutants (Part:BBa_K4361300 through Part:BBa_K4361319) were expressed in a PURE system in the presence of GreenLys (fluorescent Cy2-labeled lysine). Samples were then run on an SDS PAGE gel (Figure 1.) to determine whether or not the protein was produced. For this mutant (lane 12), a protein band corresponding to the BlcR monomer is visible. Concluding that the production in an E. coli cell-free system was successful for this mutant.